Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-07-01 | Ms. Laura SandlerCOO | -5,00k | 433,08k | Derivative Exercise and Sale | 7,80 - 95,47 | 236,38k | - |
| 2026-06-22 | Mr. Arjun AgarwalSenior VP of Finance & Treasurer | -1,59k | 128,47k | Automatic Disposition | 80,01 - 82,15 | 15,31k | -9,39% |
| 2026-06-15 | Mr. Arjun AgarwalSenior VP of Finance & Treasurer | -395,00 | 27,53k | Verkauf | 69,69 | 16,90k | -2,28% |
| 2026-06-12 | Mr. Arjun AgarwalSenior VP of Finance & Treasurer | -9,46k | 509,33k | Derivative Exercise and Sale | 12,50 - 70,34 | 16,90k | - |
| 2026-06-15 | Dr. Joana GoncalvesChief Medical Officer | -947,00 | 66,00k | Verkauf | 69,69 | 32,72k | -2,81% |
| 2026-06-15 | Dr. Joana GoncalvesChief Medical Officer | -7,00k | 433,37k | Derivative Exercise and Sale | 6,84 - 70,62 | 32,72k | - |
| 2026-06-15 | Dr. Lawrence Otto KleinPresident, CEO & Director | -1,73k | 120,49k | Verkauf | 69,69 | 925,58k | -0,19% |
| 2026-06-15 | Ms. Laura SandlerCOO | -600,00 | 41,81k | Verkauf | 69,69 | 236,38k | -0,25% |
| 2026-06-15 | Mr. Paul T. QuinlanGeneral Counsel & Secretary | -733,00 | 51,08k | Verkauf | 69,69 | 31,03k | -2,31% |
| 2026-06-11 | Dr. Carl Linden DambkowskiIndependent Director | -35,00k | 2,45M | Automatic Disposition | 70,11 - 70,13 | 38,74k | -47,46% |
| 2026-05-21 | Dr. Carl Linden DambkowskiIndependent Director | -42,74k | 2,54M | Automatic Disposition | 59,10 - 59,97 | 73,74k | -36,69% |
| 2026-05-21 | Dr. Carl Linden DambkowskiIndependent Director | -62,26k | 3,16M | Derivative Exercise and Sale | 6,84 - 59,10 | 73,74k | - |
| 2026-05-18 | Mr. Arjun AgarwalSenior VP of Finance & Treasurer | -2,46k | 147,72k | Automatic Disposition | 59,19 - 61,16 | 16,41k | -13,03% |
| 2026-05-18 | Mr. Arjun AgarwalSenior VP of Finance & Treasurer | -7,83k | 234,49k | Derivative Exercise and Sale | 12,50 - 59,19 | 16,41k | - |
| 2026-05-15 | Dr. Joana GoncalvesChief Medical Officer | -7,00k | 381,70k | Derivative Exercise and Sale | 6,84 - 63,52 | 33,38k | - |
| 2026-05-01 | Ms. Laura SandlerCOO | -5,00k | 280,38k | Derivative Exercise and Sale | 7,80 - 68,48 | 236,98k | - |
| 2026-04-15 | Dr. Joana GoncalvesChief Medical Officer | -7,00k | 411,59k | Derivative Exercise and Sale | 6,84 - 67,38 | 33,38k | - |
| 2026-03-16 | Dr. Lawrence Otto KleinPresident, CEO & Director | -1,73k | 71,41k | Verkauf | 41,30 | 927,31k | -0,19% |
| 2026-03-16 | Mr. Arjun AgarwalSenior VP of Finance & Treasurer | -395,00 | 16,31k | Verkauf | 41,30 | 18,86k | -2,05% |
| 2026-03-16 | Ms. Laura SandlerCOO | -600,00 | 24,78k | Verkauf | 41,30 | 236,98k | -0,25% |
| 2026-03-16 | Dr. Joana GoncalvesChief Medical Officer | -7,00k | 234,85k | Derivative Exercise and Sale | 6,84 - 41,94 | 33,38k | - |
| 2026-03-16 | Dr. Joana GoncalvesChief Medical Officer | -641,00 | 26,47k | Verkauf | 41,30 | 33,38k | -1,88% |
| 2026-03-16 | Mr. Paul T. QuinlanGeneral Counsel & Secretary | -733,00 | 30,27k | Verkauf | 41,30 | 31,77k | -2,26% |
| 2026-03-02 | Ms. Laura SandlerCOO | -5,00k | 128,82k | Derivative Exercise and Sale | 7,80 - 33,81 | 237,58k | - |
| 2026-02-17 | Dr. Joana GoncalvesChief Medical Officer | -7,00k | 175,32k | Derivative Exercise and Sale | 6,84 - 32,78 | 34,02k | - |
| 2026-01-15 | Dr. Joana GoncalvesChief Medical Officer | -7,00k | 171,46k | Derivative Exercise and Sale | 6,84 - 32,24 | 1,52k | - |
| 2026-01-02 | Ms. Laura SandlerCOO | -5,00k | 101,83k | Derivative Exercise and Sale | 7,80 - 28,17 | 205,08k | - |
| 2026-01-02 | Ms. Laura SandlerCOO | -8,00k | 229,97k | Automatic Disposition | 28,17 - 29,75 | 205,08k | -3,75% |
| 2025-12-19 | Dr. Joana GoncalvesChief Medical Officer | -7,00k | 163,05k | Derivative Exercise and Sale | 6,84 - 31,58 | 1,52k | - |
| 2025-09-17 | Fairmount Funds Management LLCUnternehmen | 333,34k | 5,00M | Kauf | 15,00 | 3,71M | 9,89% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
